Home > Publications Database > Association of ADHD symptoms, pain, and tics with anti-thalamus antibodies in cerebrospinal fluid. > print

001     280055
005     20250824001736.0
024 7 _ |a 10.1016/j.jneuroim.2025.578654
|2 doi
024 7 _ |a pmid:40617165
|2 pmid
024 7 _ |a 0165-5728
|2 ISSN
024 7 _ |a 1872-8421
|2 ISSN
024 7 _ |a altmetric:177973688
|2 altmetric
037 _ _ |a DZNE-2025-00892
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Endres, Dominique
|b 0
245 _ _ |a Association of ADHD symptoms, pain, and tics with anti-thalamus antibodies in cerebrospinal fluid.
260 _ _ |a Amsterdam [u.a.]
|c 2025
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1753363952_5802
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Complex mixed presentations of severe mental disorders (SMD) with treatment resistance pose major challenges in clinical practice. The role of novel neuronal antibodies in cerebrospinal fluid (CSF) is largely unexamined in this context.A well-studied paradigmatic case of a 36-year-old female patient is reported.She presented with attention-deficit/hyperactivity disorder-like symptoms (including frequent sensory overload), severe pain (pre-diagnosed as fibromyalgia and somatoform pain disorder), and motor tics. In addition, she developed secondary depressive symptoms. Various psychopharmacological treatment attempts were unsuccessful or not tolerated. The diagnostic routine work-up with a wide range of blood tests, electroencephalography (EEG), routine magnetic resonance imaging (MRI), cerebrospinal fluid (CSF) analyses, and [18F]fluorodeoxyglucose positron emission tomography revealed no clear pathological findings. Tissue-based assays using CSF material found strong immunoglobulin G antibody staining specifically directed against a cell population in the thalamus. Neurotransmitter measurements detected low GABA, glutamate and serotonin concentrations as well as high dopamine levels in the CSF. Different MRI-based analyses indicated no neurostructural alterations in the thalamus; however, left mesiotemporal volume loss was identified. The independent component analysis of the EEG showed left temporal theta waves, partly resembling spike-wave-complexes. Immunotherapy using high-dose steroids resulted in a partial improvement with subjectively reduced stimulus overload, intermediate disappearance of pain, and fewer tics. The improvement could not be objectified psychometrically/neuropsychologically. The mesiotemporal volume loss was no longer present. There were no relevant changes in further research MRI measurements of the thalamus including arterial spin labeling, diffusion tensor imaging, and diffusion microstructure imaging from pre to post-immunotherapy.Novel antibodies against strategic brain structures, such as the thalamus, might be associated with some complex SMD. Further immunopsychiatric research in this direction holds promise for a better understanding of similar patients.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Autoimmune
|2 Other
650 _ 7 |a Brain
|2 Other
650 _ 7 |a Immunotherapy
|2 Other
650 _ 7 |a Inflammation
|2 Other
650 _ 7 |a Tourette
|2 Other
650 _ 7 |a Autoantibodies
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Attention Deficit Disorder with Hyperactivity: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Attention Deficit Disorder with Hyperactivity: complications
|2 MeSH
650 _ 2 |a Attention Deficit Disorder with Hyperactivity: immunology
|2 MeSH
650 _ 2 |a Attention Deficit Disorder with Hyperactivity: diagnostic imaging
|2 MeSH
650 _ 2 |a Pain: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Pain: complications
|2 MeSH
650 _ 2 |a Pain: diagnostic imaging
|2 MeSH
650 _ 2 |a Pain: immunology
|2 MeSH
650 _ 2 |a Autoantibodies: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Thalamus: immunology
|2 MeSH
650 _ 2 |a Thalamus: diagnostic imaging
|2 MeSH
650 _ 2 |a Tics: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Tics: complications
|2 MeSH
650 _ 2 |a Tics: diagnostic imaging
|2 MeSH
650 _ 2 |a Tics: immunology
|2 MeSH
700 1 _ |a von Zedtwitz, Katharina
|b 1
700 1 _ |a Rau, Alexander
|b 2
700 1 _ |a Feige, Bernd
|b 3
700 1 _ |a Mast, Hansjörg
|b 4
700 1 _ |a Maier, Alexander
|b 5
700 1 _ |a Reisert, Marco
|b 6
700 1 _ |a Nickel, Kathrin
|b 7
700 1 _ |a Brumberg, Joachim
|b 8
700 1 _ |a Boettler, Tobias
|b 9
700 1 _ |a Glaser, Cornelia
|b 10
700 1 _ |a Venhoff, Nils
|b 11
700 1 _ |a Urbach, Horst
|b 12
700 1 _ |a Baldermann, Juan C
|b 13
700 1 _ |a Domschke, Katharina
|b 14
700 1 _ |a Tebartz van Elst, Ludger
|b 15
700 1 _ |a Hannibal, Luciana
|b 16
700 1 _ |a Prüss, Harald
|0 P:(DE-2719)2810931
|b 17
|u dzne
700 1 _ |a Maier, Simon J
|b 18
773 _ _ |a 10.1016/j.jneuroim.2025.578654
|g Vol. 406, p. 578654 -
|0 PERI:(DE-600)1500497-1
|p 578654
|t Journal of neuroimmunology
|v 406
|y 2025
|x 0165-5728
856 4 _ |u https://pub.dzne.de/record/280055/files/DZNE-2025-00892.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/280055/files/DZNE-2025-00892.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:280055
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 17
|6 P:(DE-2719)2810931
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-07
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J NEUROIMMUNOL : 2022
|d 2025-01-07
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0
|0 LIC:(DE-HGF)CCBYNC4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-07
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-07
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2025-01-07
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-07
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2025-01-07
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-07
920 1 _ |0 I:(DE-2719)1810003
|k AG Prüß
|l Autoimmune Encephalopathies
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1810003
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21